10 November 2020>: Original Paper
Renal Function in Patients with or without a Left Ventricular Assist Device Implant During Listing for a Heart Transplant
Armin Zittermann 1ABCDEF* , Rene Schramm 1DE , Tobias Becker 1BC , Ellen von Rössing 1BC , Detlef Hinse 2BC , Stefan Wlost 1BC , Michiel Morshuis 1BD , Jan F. Gummert 1BD , Uwe Fuchs 1ABDDOI: 10.12659/AOT.925653
Ann Transplant 2020; 25:e925653
Table 2 Creatinine and estimated glomerular filtration rates by study group.
LVAD group n=139 | Non-LVAD group n=1038 | P-value* | |
---|---|---|---|
Last creatinine before LVAD implant (mg/dl) | 1.30 (0.95–1.75) | – | – |
Last creatinine before listing (mg/dl) | 0.96 (0.77–1.20) | 1.20 (0.93–1.50) | 0.001 |
First creatinine after listing (mg/dl) | 0.99 (0.80–1.20) | 1.20 (0.95–1.50) | 0.004 |
Last creatinine on the waiting list (mg/dl) | 1.20 (1.00–1.60) | 1.30 (1.00–1.70) | 0.48 |
Last eGFR before LVAD implant (ml/min/1.73 m) | 60.3 (40.2–87.7) | – | – |
Last eGFR before listing (ml/min/1.73 m) | 85.6 (67.8–108.5) | 68.6 (52.2–88.9) | |
First eGFR after listing (ml/min/1.73 m) | 84.5 (66.7–106.4) | 66.2 (50.3–87.6) | 0.002 |
Last eGFR on the waiting list (ml/min/1.73 m) | 66.0 (47.0–86.9) | 59.7 (44.1–80.8) | 0.75 |
LVAD – left ventricular assist device; eGFR – estimated glomerular filtration rate. * Between-groups comparisons are based on ANCOVA with adjustments for those baseline characteristics that differed significantly between study groups (see ). |